Literature DB >> 21796346

Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study.

V G Alexiou1, A Michalopoulos, G C Makris, G Peppas, G Samonis, M E Falagas.   

Abstract

We sought to identify risk factors for postoperative infections, caused by multi-drug-resistant gram-negative bacteria (MDR-GNB) in surgical patients. This was a retrospective cohort study among patients hospitalized in the intensive care unit (ICU) for more than 5 days, following general surgical operations. Comparison of patients who developed infection caused by MDR-GNB with the remainder of the cohort showed that every minute of operative time, use of special treatments during hospitalization (antineoplastic, immunosuppressive or immunomodulating therapies), every day of metronidazole, and every day of carbapenems use, increased patients' odds to acquire an infection caused by MDR-GNB by 0.7%, 8.9 times, 9%, and 9%, respectively [OR (95% CI): 1.007 (1.003-1.011), p = 0.001; 8.9 (1.8-17.3), p = 0.004; 1.09 (1.04-1.18), p = 0.039; 1.09 (1.01-1.18), p = 0.023, respectively]. The above were adjusted in the multivariable analysis for the confounder of time distribution of infections caused by MDR-GNB. Finally, the secondary comparison, with patients that did not develop any infection, showed that patients who had received antibiotics, within 3 months prior to admission, had 3.8 times higher odds to acquire an infection caused by MDR-GNB [OR (95% CI): 3.8 (1.07-13.2), p = 0.002]. This study depicts certain, potentially modifiable, risk factors for postoperative infections in patients hospitalized in the ICU for more than 5 days.

Entities:  

Mesh:

Year:  2011        PMID: 21796346     DOI: 10.1007/s10096-011-1347-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  40 in total

1.  Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.

Authors:  M del Mar Tomas; M Cartelle; S Pertega; A Beceiro; P Llinares; D Canle; F Molina; R Villanueva; J M Cisneros; G Bou
Journal:  Clin Microbiol Infect       Date:  2005-07       Impact factor: 8.067

Review 2.  Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature.

Authors:  M E Falagas; P Kopterides
Journal:  J Hosp Infect       Date:  2006-07-05       Impact factor: 3.926

Review 3.  Postoperative complications following surgery for rectal cancer.

Authors:  Bogdan C Paun; Scott Cassie; Anthony R MacLean; Elijah Dixon; W Donald Buie
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

Review 4.  Hospital-acquired infections due to gram-negative bacteria.

Authors:  Anton Y Peleg; David C Hooper
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

Review 5.  Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience.

Authors:  Chun-Yi Lee; Po-Yen Chen; Fang-Liang Huang; Chen-Fu Lin
Journal:  J Microbiol Immunol Infect       Date:  2009-04       Impact factor: 4.399

6.  Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.

Authors:  Min-Hyok Jeon; Sang-Ho Choi; Yee Gyung Kwak; Jin-Won Chung; Sang-Oh Lee; Jin-Yong Jeong; Jun Hee Woo; Yang Soo Kim
Journal:  Diagn Microbiol Infect Dis       Date:  2008-11-06       Impact factor: 2.803

7.  Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer.

Authors:  L H Iversen; S Bülow; I J Christensen; S Laurberg; H Harling
Journal:  Br J Surg       Date:  2008-08       Impact factor: 6.939

8.  Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?

Authors:  Annabelle D Donaldson; Lubna Razak; Li Jia Liang; Dale A Fisher; Paul A Tambyah
Journal:  Int J Antimicrob Agents       Date:  2009-09       Impact factor: 5.283

9.  Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

Authors:  M B Edmond; J F Ober; D L Weinbaum; M A Pfaller; T Hwang; M D Sanford; R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

10.  Prolonged operative time correlates with increased infection rate after total knee arthroplasty.

Authors:  G Peersman; R Laskin; J Davis; M G E Peterson; T Richart
Journal:  HSS J       Date:  2006-02
View more
  4 in total

1.  Management of Intra-abdominal Infections due to Carbapenemase-Producing Organisms.

Authors:  Paola Di Carlo; Francesco Vitale; Criostóir O'Súilleabháin; Alessandra Casuccio
Journal:  Curr Infect Dis Rep       Date:  2014-10       Impact factor: 3.725

2.  Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.

Authors:  Sameer J Patel; André P Oliveira; Juyan Julia Zhou; Luis Alba; E Yoko Furuya; Scott A Weisenberg; Haomiao Jia; Sarah A Clock; Christine J Kubin; Stephen G Jenkins; Audrey N Schuetz; Maryam Behta; Phyllis Della-Latta; Susan Whittier; Kyu Rhee; Lisa Saiman
Journal:  Am J Infect Control       Date:  2014-04-13       Impact factor: 2.918

3.  KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients.

Authors:  Paola Di Carlo; Gaspare Gulotta; Alessandra Casuccio; Gianni Pantuso; Maurizio Raineri; Clizia Airò Farulla; Sebastiano Bonventre; Giuliana Guadagnino; Daniela Ingrassia; Gianfranco Cocorullo; Caterina Mammina; Antonino Giarratano
Journal:  BMC Anesthesiol       Date:  2013-07-03       Impact factor: 2.217

4.  A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.

Authors:  Anupama Vasudevan; Amartya Mukhopadhyay; Jialiang Li; Eugene Goh Yu Yuen; Paul Ananth Tambyah
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.